Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052039
Status:
TERMINATED
Last Update Posted:
2007-11-06
First Post:
2003-01-21
Brief Title:
A Randomized Double-Blind Three-Arm Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine and Azathioprine Alone in Patients With IPF Receiving Prednisone
Sponsor:
InterMune
Organization:
InterMune
Study Overview
Official Title:
A Randomized Double-Blind Three-Arm Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone IFN-Gamma 1b With Azathioprine and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving Prednisone
Status:
TERMINATED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study design changes were needed based on GIPF-001 results
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study GIPF-003 is a Phase 3b study designed to define better therapeutic use of IFN-gamma 1b in patients wtih IPF The study will be conducted primarily in Europe and will enroll 210 patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None